Mark Hensley
Corporate Officer/Principal presso VELOXIS PHARMACEUTICALS A/S
Posizioni attive di Mark Hensley
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | 03/01/2019 | - |
| Vendite & Marketing | 01/04/2016 | 03/01/2019 |
Storia della carriera di Mark Hensley
Formazione di Mark Hensley
| University of North Texas | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Danimarca | 2 |
| Stati Uniti | 2 |
Posizioni
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Mark Hensley
- Esperienza
